Co-Administration of Adjuvanted Recombinant

Authors

• Lisa Luu
• Germanus S Bah
• Ndode Herman Okah-Nnane
• Catherine S Hartley
• Alexandra F Glover
• Tessa R Walsh
• Lu-Yun Lian
• Bin Zhan
• Maria Elena Bottazzi
• David Abraham
• Nikolai Petrovsky
• Nicolas Bayang
• Bernard Tangwa
• Rene Billingwe Ayiseh
• Glory Enjong Mbah
• David D Ekale
• Vincent N Tanya
• Sara Lustigman
• Benjamin L Makepeace
• John Graham-Brown

Publication/Presentation Date

5-27-2022

Abstract

Onchocerciasis (river blindness), caused by the filarial nematode

Volume

10

Issue

6

ISSN

2076-393X

Published In/Presented At

Luu, L., Bah, G. S., Okah-Nnane, N. H., Hartley, C. S., Glover, A. F., Walsh, T. R., Lian, L. Y., Zhan, B., Bottazzi, M. E., Abraham, D., Petrovsky, N., Bayang, N., Tangwa, B., Ayiseh, R. B., Mbah, G. E., Ekale, D. D., Tanya, V. N., Lustigman, S., Makepeace, B. L., & Graham-Brown, J. (2022). Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis. Vaccines, 10(6), 861. https://doi.org/10.3390/vaccines10060861

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

35746469

Department(s)

Administration and Leadership

Document Type

Article